Loading
Latest filing published 15 Sept 2016 for Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.).
No signal scores available.
James Moodie Rae discloses dealings in Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) to SEDI. We count 2 filings; the first trade dates from 25 September 2015 and the latest from 29 February 2016.
Every open-market trade on record is a purchase: 1 purchase worth €6,757, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 option exercise. In 2016 alone, the filings show 1 purchase and no sales.
The record was last updated on 15 September 2016 with an option exercise in Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.). The last insider purchase was made public on 4 March 2016, 3,886 days ago. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations